Category: Companionship

Artificial Intelligence (AI) is transforming the fight against cancer.The European Cancer Organisation’s “Harnessing AI for Cancer Care in Europe” report

Artificial Intelligence (AI) is transforming the fight against cancer, enabling machines to learn, reason, and assist humans in detecting, diagnosing and treating the disease more accurately and efficiently. It works by analysing vast amounts of data, learning patterns, and making predictions or recommendations to support human decision-making.

Cancer care is rapidly transforming with the use of AI, which serves as a powerful tool in prevention, detection, treatment and research of the disease. The European Cancer Organisation’s “Harnessing AI for Cancer Care in Europe” report states that AI has the potential to transform every stage of the cancer pathway. Simultaneously, the report emphasises the need for AI to be used responsibly, by protecting patients, upholding ethical standards, and aligning with European values, to ensure its benefits are delivered fairly and effectively across healthcare systems.

The Promise of AI in Cancer Care

The report highlights several ways AI can improve cancer outcomes across the care pathway. In primary prevention, AI can analyse genetic, environmental, and lifestyle data to identify high-risk patients and guide preventive strategies before symptoms appear. For early detection, AI can dramatically speed up screening, reducing test interpretation from days to hours, improving accuracy, and lowering missed diagnoses. In diagnostics, deep-learning models trained on large datasets can detect even the smallest lesions, prioritise urgent cases, and support more precise diagnoses. AI also enables personalised treatment by integrating tumour genomics, imaging data, and real-world outcomes to help clinicians select the most effective therapies for individual patients. Finally, in drug development, AI can identify promising compounds and targets, shortening traditional development cycles and discovering new uses for existing medicines.

Challenges That Cannot Be Ignored

However, the report also highlights significant risks associated with AI in cancer care. Key concerns include regulatory gaps as AI tools advance faster than current rules, making it challenging to ensure they remain safe, accurate, and accountable. Many promising AI systems require further validation in real-world clinical settings, as untested tools could lead to misdiagnoses or unsafe decisions. Bias and inequity are also risks, since AI trained on unrepresentative data may produce less accurate recommendations for specific patient groups. Implementation barriers, such as limited infrastructure, funding, and trained staff, can hinder the integration of AI into everyday healthcare. Finally, trust issues may arise, as both patients and clinicians need to understand and have confidence in AI systems for them to be effectively adopted.

Policy Recommendations: A Roadmap for Safe and Effective Use

To tackle these challenges, the report puts forward four key recommendations. First, it calls for national standards and validation frameworks, including speciality-specific rules and post-market monitoring of AI tools. Second, it emphasises the importance of training and literacy, proposing pan-European AI education to ensure that at least 50% of oncology professionals are confident in using AI by 2030. Third, the report urges robust regulatory guidance and oversight, including EU-wide support for data protection under GDPR, implementation of the AI Act, and strong patient engagement to ensure clinical accountability. Finally, it highlights the need for investment in data infrastructure, leveraging the European Health Data Space to harmonise systems, modernise cancer registries, and build representative datasets that support safe and effective AI deployment.

Why This Matters for Kapa3

Building on these advancements, K3 is preparing to launch its digital assistant, “Myrto”, in 2026. Designed to harness the power of AI, “Myrto” will support patients and healthcare professionals across the cancer care pathway. By integrating cutting-edge AI capabilities with user-friendly guidance, “Myrto” exemplifies K3’s commitment to improving outcomes, streamlining workflows, and empowering both patients and clinicians in Europe’s rapidly evolving healthcare landscape.

To see the full article, please click here.

https://www.europeancancer.org/resources/publications/harnessing-ai-for-cancer-care-in-europe.html

The Power of Social Support in Cancer Care

Why connection is as vital as treatment

Mental health professionals consistently emphasise the value of a strong social support network. Social support is among the strongest predictors of emotional well-being and overall quality of life. It refers to the extent to which our social and emotional needs are met through the people and communities around us, such as family, friends, colleagues, and groups that share our values and experiences.

Group interventions, for example, have been shown to reduce psychological stress by providing individuals with chronic illnesses the opportunity to connect and share experiences (Jackson et al., 2019).  Studies have found that cancer patients who felt more supported by family, friends, or their community experienced less distress, coped more effectively, and had a greater sense of control during treatment. Tangible support, in particular, was more significant for older patients, who may face greater physical challenges due to age or disability (Ahmad et al., 2013).

Furthermore, social support fosters optimism and resilience, which are key factors that help patients adapt to illness. By strengthening hope and inner confidence, social connections help protect against anxiety and depression, acting as a buffer against the emotional impact of stress (Ruiz-Rodríguez et al., 2022).

But what comes first — support or coping? The systematic review by Bottaro and colleagues (2023) suggests the relationship is bidirectional: people who receive strong support cope better, and those who cope better are more likely to seek and maintain strong relationships. It’s a cycle of connection that reinforces recovery.

The source of support also plays a crucial role. Patients often view family, friends, and partners as the most important sources of support for coping with diagnosis and treatment. However, when the type of support offered doesn’t align with the patient’s needs, it can feel less meaningful or even unhelpful.

While loved ones form the core of emotional care, healthcare professionals are often the first and most consistent source of reassurance. According to the literature, patients who feel heard, respected, and well-informed by their medical team cope more effectively and experience less anxiety. Ruiz-Rodríguez and colleagues highlight that optimism and resilience grow when medical staff communicate openly and offer encouragement. Compassionate communication from healthcare providers strengthens patients’ ability to manage their illness, creating a positive feedback loop between support and wellbeing (Bottaro et al., 2023).

At Kapa3, we witness this truth daily. Through our community programs, research, and advocacy, we work to create environments where no one faces cancer alone. Social support is not only emotional, it’s practical, cultural, and profoundly human. Healing doesn’t happen only in hospitals; it happens in homes, workplaces, and communities.

 References

Ahmad, M., Khan, M. A., & Shirazi, M. (2013). Perception of Social Support by Cancer Patients. International Journal of Psychology and Behavioral Sciences, 3(5), 115–122. https://doi.org/10.5923/j.ijpbs.20130305.01

Bottaro, R., Craparo, G., & Faraci, P. (2023). What is the direction of the association between social support and coping in cancer patients? A systematic review. Journal of Health Psychology, 28(6), 135910532211311. https://doi.org/10.1177/13591053221131180

Jackson, M., Jones, D., Dyson, J., & Macleod, U. (2019). Facilitated group work for people with long-term conditions: A systematic review of benefits from studies of group-work interventions. British Journal of General Practice, 69(682), 363–372. https://doi.org/10.3399/bjgp19x702233

Ruiz-Rodríguez, I., Hombrados-Mendieta, I., Melguizo-Garín, A., & Martos-Méndez, M. J. (2022). The importance of social support, optimism and resilience on the quality of life of cancer patients. Frontiers in Psychology, 13. https://doi.org/10.3389/fpsyg.2022.833176

 

Article by: Despina Chrysostomidou, Psychologist for Kapa3 Research Insights

 

World Animal Day: The Healing Presence of Animals

World Animal Day reminds us that we share the planet with all living beings.

Animals are not just companions in our lives; they are an essential part of the balance of nature and our daily world. For many patients, having a pet provides comfort, affection, and a unique bond that eases life’s challenges.

The idea of World Animal Day began in 1925 with Heinrich Zimmermann, who organized the first celebration in Berlin. By 1931, October 4th became officially recognized as a day for all animals. The date is also connected to the feast of Saint Francis of Assisi, the patron saint of animals, symbolizing care and respect for all creatures.

For those fighting cancer, the presence of an animal can be therapeutic. Pet companionship reduces anxiety, brings smiles, and strengthens emotional resilience. Many hospitals abroad use “pet therapy” programs where interaction with animals helps patients feel less alone and more empowered.

At the Kapa3 Cancer Guidance Center, we understand that patient care goes beyond treatment. Mental and emotional well-being is equally important. The power of love—even from a cat or dog—reminds us that no one should walk the path of cancer alone.

World Animal Day calls us to respect all creatures and remember that kindness and affection, wherever we find them, are forms of healing.

You can read more here:

https://nationaltoday.com/world-animal-day/

About Us